Mark B. Carbeau

Mark B. Carbeau

Plus aucun poste en cours

63 ans
Health Technology
Distribution Services
Commercial Services

Profil

Mark B.
Carbeau
is the founder of CM Partners LLC, Diagnostyx, Inc. He was the Chief Executive Officer of Interleukin Genetics, Inc. in 2015, Chairman & Chief Executive Officer of Nuvesse Skin Therapies, Inc. in 2013, President & Chief Executive Officer of HyperMed, Inc. in 2008-2009, and President-USA Division of Kinetic Concepts, Inc. in 2005-2007.
He also worked as a Marketing Officer at Eli Lilly & Co. and as a Vice President-Corporate Development at OraPharma, Inc. He started his career as a Manager at The Boston Consulting Group, Inc. He holds an undergraduate degree from The Pennsylvania State University and an MBA from The Wharton School of the University of Pennsylvania.

Anciens postes connus de Mark B. Carbeau

SociétésPosteFin
INTERLEUKIN GENETICS, INC Directeur Général 24/07/2017
Directeur Général 01/06/2013
Directeur Général 07/10/2009
Corporate Officer/Principal 30/06/2007
Directeur/Membre du Conseil -
Voir l'expérience en détail de Mark B. Carbeau

Formation de Mark B. Carbeau

The Pennsylvania State University Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Mark B. Carbeau

Relations

36

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
ELI LILLY AND COMPANY

Health Technology

Entreprise privées9

Health Technology

Health Technology

Health Technology

Distribution Services

Commercial Services

Commercial Services

Distribution Services

Diagnostyx, Inc.

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Mark B. Carbeau